发明授权
US08088784B2 4-(3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer
失效
用作酪氨酸激酶抑制剂治疗癌症的4-（3-氨基吡唑）嘧啶衍生物
- 专利标题： 4-(3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer
- 专利标题（中）： 用作酪氨酸激酶抑制剂治疗癌症的4-（3-氨基吡唑）嘧啶衍生物
-
申请号： US12713695申请日： 2010-02-26
-
公开(公告)号： US08088784B2公开(公告)日： 2012-01-03
- 发明人: Xiaomei Feng , Huiping Guan , Ying Kang , Stephanos Ioannidis , Bo Peng , Mei Su , Bin Wang , Tao Wang , Hai-Jun Zhang
- 申请人： Xiaomei Feng , Huiping Guan , Ying Kang , Stephanos Ioannidis , Bo Peng , Mei Su , Bin Wang , Tao Wang , Hai-Jun Zhang
- 申请人地址： SE Sodertalje
- 专利权人： AstraZeneca AB
- 当前专利权人： AstraZeneca AB
- 当前专利权人地址： SE Sodertalje
- 主分类号： C07D403/14
- IPC分类号： C07D403/14 ; A61K31/506
摘要：
This invention relates to novel compounds having the formula (I) and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment for cancer.
公开/授权文献
信息查询
